<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04556019</url>
  </required_header>
  <id_info>
    <org_study_id>CIRUGIA HPB-CHN</org_study_id>
    <nct_id>NCT04556019</nct_id>
  </id_info>
  <brief_title>Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit</brief_title>
  <acronym>HPB</acronym>
  <official_title>Results of the Surgical Treatment of Patients From Hepatobiliopancreatic Surgical Unit at the Complejo Hospitalario de Navarra</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion Miguel Servet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion Miguel Servet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aims of this study are:&#xD;
&#xD;
        1. - to evaluate post-surgical morbidity and mortality outcomes, following the criteria and&#xD;
           the definitions from Claven-Dindo and ISGPS international classifications, of the&#xD;
           patients operated by the HPB Surgical Unit.&#xD;
&#xD;
        2. - to evaluate survival and disease-free survival rates of the patients operated by the&#xD;
           HPB Surgical Unit due to tumoral cause.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 3, 2019</start_date>
  <completion_date type="Anticipated">January 2029</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of patient with post-surgical morbidity and mortality operated by the HPB Surgical Unit</measure>
    <time_frame>90 days post-surgery</time_frame>
    <description>Morbidity and mortality outcomes are evaluated following the criteria and definitions from Claven-Dindo and ISGPS international classifications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Survival rate of patients operated by the HPB Surgical Unit</measure>
    <time_frame>5-years post-surgery</time_frame>
    <description>These patients are operated due to tumoral cause</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease-free survival rate of patients operated by the HPB Surgical Unit</measure>
    <time_frame>5-years post-surgery</time_frame>
    <description>These patients are operated due to tumoral cause</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of standardization of pre and post-surgical care</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the result of the multimodal treatment</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the oncological quality standards of patients operated by HPB Surgical Unit due to tumoral cause</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the results from minimally invasive techniques in HPB surgery</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Pancreas Disease</condition>
  <condition>Liver Diseases</condition>
  <condition>Surgical Procedure, Unspecified</condition>
  <condition>Bile Duct Diseases</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hepatobiliopancreatic surgery</intervention_name>
    <description>Different surgical techniques tailored to each patient´s pathology</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All out-patients and in-patients at the HPB Surgical Unit&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients operated by the HPB Surgical Unit in the last 10 years (retrospective)&#xD;
&#xD;
          -  All patients being operated by the HPB Surgical Unit from January 2019 onwards who&#xD;
             provide inform consent (prospective).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not eligible for surgery&#xD;
&#xD;
          -  Patients not interested in taking part in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francisco Javier Herrera Cabezón, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Complejo Hospitalario de Navarra</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francisco Javier Herrera Cabezón, MD</last_name>
    <phone>0034 848422187</phone>
    <email>javier.herrera.cabezon@cfnavarra.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pablo Sánchez Acedo, MD</last_name>
    <phone>0034 848422187</phone>
    <email>pablosanchez_84@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Sánchez, MD</last_name>
      <phone>0034 848422187</phone>
      <email>pablosanchez_84@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ruth García Rey, MSc</last_name>
      <phone>0034 848422163</phone>
      <email>ruth.garcia.rey@navarra.es</email>
    </contact_backup>
    <investigator>
      <last_name>Francisco Javier Herrera Cabezón, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pablo Sánchez Acedo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cruz Zazpe Ripa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Tarifa Castilla, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 11, 2019</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hepatobiliopancreatic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Bile Duct Diseases</mesh_term>
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

